May 2012

 

Issue

Insert

Supplement

Editor's Page

A Lost Opportunity for Chronic DME

By Robert L. Avery, MD; and Allen C. Ho, MD

Vail Vitrectomy: Controversial Elitism or Educational Masterpiece?

By Kirk H. Packo, MD, FACS Chair, Vail Vitrectomy Scientific Program and Organizing Committee

Business of Retina
Pennsylvania Avenue Updates

The Physician Payments Sunshine Act

Will this legislation impede collaboration between physicians and industry?
With William L. Rich III, MD

Clinical Trials for the Retina Specialist

Recruiting for Invasive Clinical Trials

By Aron Shapiro and Ashley Lafond

Fellows’ Focus

Financial Advice for Young Physicians

By Andre Witkin, MD; Alok S. Bansal, MD; and Nik London, MD

Retina Surgery
Retina Pearls

Valved Cannula Systems

This technology promotes safe and efficient vitrectomy surgery.

By Daniel D. Esmaili, MD

Global Perspectives

Combined Phacoemulsification and Pars Plana Vitrectomy

Combining these procedures benefits both the surgeon and the patient.

By Francesco Barca, MD; and Stanislao Rizzo, MD

Surgical Updates

The Advent of Chandelier Illumination in Vitreoretinal Surgery

A panel of surgeons has divergent views on when and how to use these devices.

By Rohit Ross Lakhanpal, MD, FACS; and the Vit-Buckle Society

Oncology
Case Reports in Ocular Oncology

Detection of a Second Primary Tumor During Whole-body Positron Emission Tomography for Choroidal Melanoma

By Pradeep Venkatesh, MD; Prakash Agarwal, MD; Rakesh Kumar, MD; and Satpal Garg, MD

Cover Stories

Ocular Drug Delivery Systems for the Posterior Segment: A Review

By Noriyuki Kuno, PhD; and Shinobu Fujii

Fluocinolone Implant Will Be Welcome Addition to Therapy Options for DME

UK physician shares impressions from FAME Study.

By Andrew J. Lotery, MD, FRCOphth

Sustained Delivery for Retinal Vein Occlusion

For many patients, this method of drug delivery is preferable to rapid attenuation.

By Antonio Capone Jr., MD

Drug Delivery Implants for Geographic Atrophy

A number of sustained-delivery technologies are under study.

By Baruch D. Kuppermann, MD, PhD

Is Dry AMD Treatable?

A new ophthalmic solution may halt disease progression.

By George Chiou, PhD

Are Topical Antibiotics Helpful as Prophylaxis for Intravitreal Injections?

The community standard is evolving toward focusing on antisepsis.

By Charles Wykoff, MD, PhD; and Harry W. Flynn Jr., MD

Medical Retina

Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery

A clinical study finds the technique effective in treatment of complicated retinal detachments.
P.V. Lyskin, MD, PhD; and Elena G. Kazimirova, MD

New Instrumentation

A New Scleral Depressor

This new instrument is designed to allow for more effective examination of the fundus while being more comfortable and ergonomic for both the physician and patient.

By Robert G. Josephberg, MD; and Eduardo Besser, MD

Departments

5Q With Hugo Quiroz-Mercado, MD

Dr. Quiroz-Mercado is the Director of Ophthalmology at the Denver Health Medical Center and a Professor of Ophthalmology at the Rocky Mountain Lions Eye Institute, University of Colorado.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Bryan Bechtel
Editor-in-Chief
484-581-1827
bbechtel@bmctoday.com

Alan B. Guralnick
Publisher
484-581-1832
aguralnick@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.

Website Design by Sides Media